无症状烟雾病五年卒中风险及其预测因素:无症状烟雾病登记研究(AMORE)
日本多中心前瞻性队列研究纳入109例无症状烟雾病患者,103例完成5年随访。烟雾病半球年卒中风险为1.0%,多数为出血性卒中。2级脉络膜吻合可能预测卒中,微出血和2级脉络膜吻合可能预测出血性卒中。
要点
- 无症状烟雾病半球5年内年卒中风险为1.0%,以出血性卒中为主。
- 2级脉络膜吻合是卒中的独立预测因素(HR 5.05)。
- 微出血和2级脉络膜吻合可预测出血性卒中。
核心结论
- 无症状烟雾病半球在5年内可能承载1.0%的年卒中风险,其中多数为出血性卒中。
- 2级脉络膜吻合可能预测卒中,微出血和2级脉络膜吻合可能承载出血性卒中风险。
研究设计与样本
- 日本多中心前瞻性队列研究(无症状烟雾病登记研究),纳入20至70岁、双侧或单侧烟雾病、无提示TIA和卒中发作、功能独立(改良Rankin量表评分0-1)的患者。
- 2012年至2015年间共纳入109例患者,其中103例患者共182个受累半球完成5年随访。
主要发现
- 根据DSA和MRA表现,143个半球判定为烟雾病,39个半球为可疑表现(孤立性大脑中动脉狭窄)。
- 可疑半球患者较烟雾病半球患者显著更年长、更多为男性、更常合并高血压。
- 烟雾病半球在最初5年内发生7次卒中,包括6次出血性卒中和1次缺血性卒中。
- 年卒中风险为每人1.4%、每半球0.8%、每烟雾病半球1.0%。
- 卒中的独立预测因素为2级脉络膜吻合(风险比5.05 [95% CI, 1.24-20.6];P=0.023);微出血(风险比4.89 [95% CI, 1.13-21.3];P=0.0342)和2级脉络膜吻合(风险比7.05 [95% CI, 1.62-30.7];P=0.0093)显著预测出血性卒中;可疑半球未发生任何卒中。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long-term outcomes are unknown in patients with asymptomatic moyamoya disease. In this report, we aimed to clarify their 5-year risk of stroke and its predictors. METHODS: We are conducting a multicenter, prospective cohort study (Asymptomatic Moyamoya Registry) in Japan. Participants were eligible if they were 20 to 70 years, had bilateral or unilateral moyamoya disease, experienced no episodes suggestive of TIA and stroke; and were functionally independent (modified Rankin Scale score 0-1). Demographic and radiological information was collected at enrollment. In this study, they are still followed up for 10 years. In this interim analysis, we defined the primary end point as a stroke occurring during a 5-year follow-up period. Independent predictors for stroke were also determined, using a stratification analysis method. RESULTS: Between 2012 and 2015, we enrolled 109 patients, of whom 103 patients with 182 involved hemispheres completed the 5-year follow-up. According to the findings on DSA and MRA, 143 hemispheres were judged as moyamoya disease and 39 hemispheres as questionable manifestations (isolated middle cerebral artery stenosis). The patients with questionable hemispheres were significantly older, more often male, and more frequently had hypertension than those with moyamoya hemisphere. Moyamoya hemispheres developed 7 strokes, including 6 hemorrhagic and 1 ischemic stroke, during the first 5 years. The annual risk of stroke was 1.4% per person, 0.8% per hemisphere, and 1.0% per moyamoya hemisphere. Independent predictor for stroke was Grade-2 choroidal anastomosis (hazard ratio, 5.05 [95% CI, 1.24-20.6]; P=0.023). Furthermore, microbleeds (hazard ratio, 4.89 [95% CI, 1.13-21.3]; P=0.0342) and Grade-2 choroidal anastomosis (hazard ratio, 7.05 [95% CI, 1.62-30.7]; P=0.0093) significantly predicted hemorrhagic stroke. No questionable hemispheres developed any stroke. CONCLUSIONS: The hemispheres with asymptomatic moyamoya disease may carry a 1.0% annual risk of stroke during the first 5 years, the majority of which are hemorrhagic stroke. Grade-2 choroidal anastomosis may predict stroke, and the microbleeds and Grade-2 choroidal anastomosis may carry the risk for hemorrhagic stroke. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: UMIN000006640.
引用
- Kuroda S, Yamamoto S, Funaki T, et al. Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE). Stroke. 2023. PMID: 37216455. doi:10.1161/STROKEAHA.122.041932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。